We quote the full program cost at consultation so you know the total for the expected treatment window, not a teaser monthly number
This can lead to unintended calorie restriction beyond what the GLP-1 alone would cause, potentially accelerating weight loss but also risking nutrient deficiencies or fatigue
Programs are self-pay and transparent, covering clinical oversight, testing, and ongoing support rather than just the prescription
Maintain a healthy weight through diet and exercise
Taken together, eprenetapopt could be a promising selective agent for SWI/SNF-deficient cancer cells derived from SMARCA4-deficient lung cancers, SMARCB1-deficient rhabdoid tumors, and PBRM1-deficient kidney cancers
2022;71: Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide Altimmune